The price of quezartinib is affected by factors such as region, dosage, and purchase channel. It is not yet officially available in China, and the price per box may range from tens of thousands to hundreds of thousands of RMB. The specific cost depends on the patient's actual medication needs and strict adherence to the doctor's prescription.
I. Factors Affecting Price
Regional Differences: Pricing policies, tariffs, and distribution costs vary across different countries or regions. For example, purchasing the drug overseas (e.g., through a legitimate medical institution or pharmacy) may involve higher costs.
Dosage and Treatment Course: The dosage and duration of treatment directly affect the total cost. A single box typically contains a supply for several days to several weeks.
Purchase Channels: Since it is not available in China, some patients obtain it through overseas medical treatment, clinical trials, or designated pharmacies. The cost varies significantly depending on the channel.
II. Important Notes Regarding Costs
National Reimbursement Insurance and Commercial Insurance: Currently, this drug may not be included in the national reimbursement drug list and must be purchased out-of-pocket. Some commercial insurance policies may cover treatment costs for specific indications; it is recommended to consult your insurance provider.
Patient Assistance Programs: Some pharmaceutical companies or charitable organizations offer medication subsidies or drug donation programs. Please contact your attending physician or relevant organization to understand the application requirements.
III. Medication Safety and Standards
Prescription Drug Usage Requirements: Quetzartinib is a targeted anti-tumor drug. It requires a doctor's evaluation based on pathological type, gene testing results, etc. Self-purchase or dosage adjustment is not permitted.
Side Effect Monitoring: Adverse reactions such as bone marrow suppression and abnormal liver function may occur during medication. Regular follow-up examinations and contacting your doctor to adjust the treatment plan are necessary.
IV. Medical Guidance and Suggestions
Consult a Specialist: It is recommended to prioritize consultation with the hematology or oncology department of a tertiary hospital to obtain an individualized treatment plan.
Participate in Clinical Trials: If eligible, you can apply to join relevant drug clinical trial projects through official channels to reduce the financial burden.
For further information on specific prices or medication details, it is recommended to verify through regular medical institutions or official channels to avoid the risks of purchasing drugs through unofficial channels.
